| 000 | 00769nam a22002172 4500 | ||
|---|---|---|---|
| 001 | hsl001006971 | ||
| 003 | DGPO | ||
| 005 | 20170826152556.0 | ||
| 008 | 170117s1970 dcu f000 0 eng d | ||
| 040 |
_aGPO _cGPO _dMvI |
||
| 086 | 0 | _aHE 20.3161/A:M 581/4 | |
| 099 | _aHE 20.3161/A:M 581/4 | ||
| 245 | 0 | 0 | _aSuppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-ergocryptine. |
| 260 |
_a[Washington, D.C., _c1970] |
||
| 300 | _av. | ||
| 500 | _a[Reprinted from Journal of National Cancer Institute, v.45, no.6, Dec. 1970]. | ||
| 500 | _aCRDP Program Historic Shelflist record. | ||
| 650 | 0 |
_aBreast _xCancer. |
|
| 650 | 0 |
_aCancer _xResearch. |
|
| 710 | 2 | _aNational Cancer Institute (U.S.) | |
| 949 |
_aBEV _bFed Docs |
||
| 999 |
_c264579 _d264579 |
||